Di Palma M - Search Results

1

Relationship between the creatinine/cystatin C ratio and muscle mass measured by CT-scan in cancer patients.

Tlemsani C, Durand JP, Raynard B, Revel MP, Deluche E, Di Palma M, Pigneur F, Goldwasser F. Tlemsani C, et al. Among authors: di palma m. Clin Nutr ESPEN. 2022 Oct;51:412-418. doi: 10.1016/j.clnesp.2022.07.010. Epub 2022 Jul 31. Clin Nutr ESPEN. 2022. PMID: 36184236

2

[Detection and evaluation of malnutrition in oncology: What tools, what type of cancer and for what purposes?].

Khan S, Alibay TA, Merad M, DiPalma M, Raynard B, Antoun S. Khan S, et al. Bull Cancer. 2016 Sep;103(9):776-85. doi: 10.1016/j.bulcan.2016.06.003. Epub 2016 Jul 22. Bull Cancer. 2016. PMID: 27456260 Review. French.

3

The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study).

Raynard B, Pigneur F, Di Palma M, Deluche E, Goldwasser F. Raynard B, et al. Among authors: di palma m. Support Care Cancer. 2022 Apr;30(4):3119-3129. doi: 10.1007/s00520-021-06603-0. Epub 2021 Dec 3. Support Care Cancer. 2022. PMID: 34862578 Free PMC article.

4

Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?

Deluche E, Lachatre D, Di Palma M, Simon H, Tissot V, Vansteene D, Meingan P, Mohebi A, Lenczner G, Pigneur F, Goldwasser F, Raynard B; SCAN Study Group. Deluche E, et al. Among authors: di palma m. Breast. 2022 Feb;61:84-90. doi: 10.1016/j.breast.2021.12.014. Epub 2021 Dec 15. Breast. 2022. PMID: 34923226 Free PMC article.

5

Low skeletal muscle mass is clinically underestimated in advanced metastatic prostate cancer: the cross-sectional SCAN study.

Di Palma M, Raynard B, Pigneur F, Goldwasser F, Deluche E. Di Palma M, et al. BMJ Support Palliat Care. 2022 Sep 13:spcare-2022-003862. doi: 10.1136/spcare-2022-003862. Online ahead of print. BMJ Support Palliat Care. 2022. PMID: 36100430 No abstract available.

6

Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer.

Franzoi MA, Degousée L, Martin E, Semedo PM, Aupomerol M, Soldato D, Di Meglio A, Chiodi C, Barbier A, Chaouachi H, Renvoisé N, Boinon D, Fasse L, Ribeiro J, Le-Provost JB, Arvis J, Lazorthes C, di Palma M, de Jesus A, Raynard B, Pagès A, Delaloge S, Pistilli B, Scotté F, Vaz-Luis I. Franzoi MA, et al. Among authors: di palma m. JCO Oncol Pract. 2023 Jun;19(6):353-361. doi: 10.1200/OP.23.00016. JCO Oncol Pract. 2023. PMID: 37307673 Free PMC article.

7

Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients.

Goldwasser F, Gross-Goupil M, Tigaud JM, Di Palma M, Marceau-Suissa J, Wasserman E, Yovine A, Misset JL, Cvitkovic E. Goldwasser F, et al. Among authors: di palma m. Ann Oncol. 2000 Nov;11(11):1463-70. doi: 10.1023/a:1026535824044. Ann Oncol. 2000. PMID: 11142487 Free article. Clinical Trial.

8

Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.

Antoun S, Lanoy E, Iacovelli R, Albiges-Sauvin L, Loriot Y, Merad-Taoufik M, Fizazi K, di Palma M, Baracos VE, Escudier B. Antoun S, et al. Among authors: di palma m. Cancer. 2013 Sep 15;119(18):3377-84. doi: 10.1002/cncr.28218. Epub 2013 Jun 25. Cancer. 2013. PMID: 23801109 Free article.

9

Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer.

Rajpar S, Massard C, Laplanche A, Tournay E, Gross-Goupil M, Loriot Y, Di Palma M, Bossi A, Escudier B, Chauchereau A, Fizazi K. Rajpar S, et al. Among authors: di palma m. Ann Oncol. 2010 Sep;21(9):1864-1869. doi: 10.1093/annonc/mdq037. Epub 2010 Feb 24. Ann Oncol. 2010. PMID: 20181574 Free article.

10

Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients.

Levy A, Menard J, Albiges L, Loriot Y, Di Palma M, Fizazi K, Escudier B. Levy A, et al. Among authors: di palma m. Eur J Cancer. 2013 May;49(8):1898-904. doi: 10.1016/j.ejca.2013.02.003. Epub 2013 Mar 13. Eur J Cancer. 2013. PMID: 23490648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page